ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163664 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163664; 2) Community: the network communities that were significantly associated with the response to NSC 163664; 3) Molecule: the relationships between components within communities and NSC 163664; 4) MDR: the compounds that were significantly associated with the NSC 163664.

NSC Compound Enrichment Correlation
NSC 754118 6-chloro-7-phenyl-8-(3,5-dimethoxybenzyl)- 5,8-dihydro-4H-isoxazolo[4,5-g]indole 0.0438391811600409 0.35138599
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0438391811600409 0.055117927
NSC 755523 Null 0.0438391811600409 0.48665287
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0438391811600409 0.23698899
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0438391811600409 0.43324667
NSC 762009 Copper(II) complex with quin as a ligand 0.0438391811600409 0.49459362
NSC 763232 Null 0.0438391811600409 0.28457491
NSC 77039 Null 0.0438391811600409 0.23348478
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0438391811600409 0.49252451
NSC 87500 Solacongestidine 0.0438391811600409 0.17024212
Total:126  Current:119    [First] [Prev] [Next] [Last]